BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37039952)

  • 1. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
    Altieri R; Certo F; Pacella D; Cammarata G; Garozzo M; Broggi G; Caltabiano R; Magro G; Russo G; Cosentino S; Ippolito M; Barbagallo G
    J Neurooncol; 2023 Apr; 162(2):417-423. PubMed ID: 37039952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on
    Hirono S; Ozaki K; Kobayashi M; Hara A; Yamaki T; Matsutani T; Iwadate Y
    Sci Rep; 2021 Jul; 11(1):14554. PubMed ID: 34267303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of
    Inoue A; Watanabe H; Kusakabe K; Nishikawa M; Shiraishi Y; Taniwaki M; Takimoto Y; Harada M; Furumochi T; Shigekawa S; Kitazawa R; Kido T; Ohnishi T; Kunieda T
    Neurosurg Rev; 2023 Nov; 46(1):294. PubMed ID: 37925381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
    Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of positive tissue on methionine-PET is associated with improved survival in glioblastomas.
    Ohmura K; Daimon T; Ikegame Y; Yano H; Yokoyama K; Kumagai M; Shinoda J; Iwama T
    Brain Behav; 2023 Dec; 13(12):e3291. PubMed ID: 37846176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Met-PET uptake index for total tumor resection: identification of
    Inoue A; Ohnishi T; Kohno S; Ohue S; Nishikawa M; Suehiro S; Matsumoto S; Ozaki S; Fukushima M; Kurata M; Kitazawa R; Shigekawa S; Watanabe H; Kunieda T
    Neurosurg Rev; 2021 Feb; 44(1):587-597. PubMed ID: 32060762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
    Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
    Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final Results of the Prospective Biomarker Trial PETra: [
    Seidlitz A; Beuthien-Baumann B; Löck S; Jentsch C; Platzek I; Zöphel K; Linge A; Kotzerke J; Petr J; van den Hoff J; Steinbach J; Krex D; Schmitz-Schackert G; Falk M; Baumann M; Krause M
    Clin Cancer Res; 2021 Mar; 27(5):1351-1360. PubMed ID: 33376095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [
    Shahzadi I; Seidlitz A; Beuthien-Baumann B; Zwanenburg A; Platzek I; Kotzerke J; Baumann M; Krause M; Troost EGC; Löck S
    Sci Rep; 2024 Feb; 14(1):4576. PubMed ID: 38403632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
    Buchmann N; Kläsner B; Gempt J; Bauer JS; Pyka T; Delbridge C; Meyer B; Krause BJ; Ringel F
    World Neurosurg; 2016 May; 89():420-6. PubMed ID: 26893043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
    Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E
    Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative volumetric analysis of primary glioblastoma multiforme on MRI and 11C-methionine PET: initial study on five patients.
    Zhao J; Chen Z; Cai L; Yin S; Yang W; Wang Z
    Neurol Neurochir Pol; 2019; 53(3):199-204. PubMed ID: 30855705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.
    Riva M; Lopci E; Castellano A; Olivari L; Gallucci M; Pessina F; Fernandes B; Simonelli M; Navarria P; Grimaldi M; Rudà R; Castello A; Rossi M; Alfiero T; Soffietti R; Chiti A; Bello L
    World Neurosurg; 2019 Jun; 126():e270-e280. PubMed ID: 30797926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.
    Arbizu J; Tejada S; Marti-Climent JM; Diez-Valle R; Prieto E; Quincoces G; Vigil C; Idoate MA; Zubieta JL; Peñuelas I; Richter JA
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):771-81. PubMed ID: 22258713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.